calendar
14,968 catalysts · 3,603 8k filing · 2,670 grant · 2,420 approval · 1,702 device 510k · 1,263 device recall · 1,164 device pma
14,968 catalysts · 3,603 8k filing · 2,670 grant · 2,420 approval · 1,702 device 510k · 1,263 device recall · 1,164 device pma
DK grant. $49,538. PI: Elizabeth Frankel
NS grant. $49,538. PI: Isabel Romov
AI grant. $105,792. PI: Lynn El Haddad
AI grant. $303,969. PI: Najib M El-Sayed
CA grant. $75,520. PI: Nicole Mihalik
AG grant. $51,038. PI: Siling Du
AI grant. $91,297. PI: Joseph J Eron
AI grant. $264,444. PI: Kiat Ruxrungtham
AI grant. $1. PI: Dan H. Barouch
AI grant. $1. PI: Dan H. Barouch
AI grant. $1. PI: Dan H. Barouch
AI grant. $90,688. PI: Joseph J Eron
AI grant. $288,709. PI: Joseph J Eron
AI grant. $1. PI: Joseph J Eron
AI grant. $105,412. PI: Joseph J Eron
AI grant. $75,000. PI: Alberto La Rosa
CA grant. $350,599. PI: Shanshan Jiang
AI grant. $110,922. PI: David Guy Kirsch
GM grant. $189,459. PI: Konstantinos Sousounis
HL grant. $78,040. PI: Megan Aumann
AA grant. $75,520. PI: Christopher D Walker
CA grant. $41,876. PI: Molly Guthrie
NS grant. $44,020. PI: Henry Kyoung
DK grant. $42,418. PI: Morgan Harwood
DC grant. $46,145. PI: Hannah McCalmon
DC grant. $38,922. PI: Alyssa Luz-Ricca
CA grant. $406,351. PI: Patrick Bhola
AI grant. $35,137. PI: Joseph J Eron
AG grant. $45,294. PI: Robyn Jo McCartan
EB grant. $74,632. PI: Calder Sheagren
AI grant. $193,508. PI: Joseph J Eron
EY grant. $83,224. PI: Andrew Howard Miller
CA grant. $691,400. PI: Erin Lynn Van Blarigan
HL grant. $145,044. PI: Brian T. Palmisano
Sponsor: ELITE LABS INC. Form: TABLET. Route: ORAL
Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION
Sponsor: TORRENT PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: LOXO ONCOL. Form: TABLET. Route: ORAL
Sponsor: NANJING KING FRIEND. Form: INJECTABLE. Route: INJECTION
Sponsor: KNACK. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: SANDOZ. Form: TABLET. Route: ORAL
Product code: NGT. Advisory committee: General Hospital. Type: Traditional
Product code: NAY. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: FBK. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: SGT. Advisory committee: Physical Medicine. Type: Traditional
Product code: QIH. Advisory committee: Radiology. Type: Traditional
Supplement type: 30-Day Notice. Product code: PNJ. Advisory committee: CV. Decision: OK30
Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815509420 Software Version: N/A Product Description: Affixus 9 mm, Length 420 mm, Right, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing
Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815509380 Software Version: N/A Product Description: Affixus 9 mm, Length 380 mm, Right, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing
Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815609320 Software Version: N/A Product Description: Affixus 9 mm, Length 320 mm, Left, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing